结直肠癌机会性筛查在粪便隐血阳性住院患者中的临床应用价值<sup>*</sup>

doi:10.3969/j.issn.1671-7171.2024.03.003

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1178 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the clinical application value of opportunistic screening for colorectal cancer in hospitalized patients with positive stool occult blood test. 【Methods】A retrospective analysis was conducted on the clinical data of 534 hospitalized patients with positive stool occult blood test who underwent opportunistic screening for colorectal cancer at the Fourth Affiliated Hospital of Zhejiang University School of Medicine from July 2021 to July 2022. According to the classification criteria for high-risk populations of colorectal cancer, patients were divided into high-risk group(n=99) and general population group(n=435). The stool occult blood test and colonoscopy were analyzed, and the colonoscopy results were compared among different groups. 【Results】 534 hospitalized patients underwent routine stool occult blood test, all of which were positive. Among them, 278 patients underwent colonoscopy, with a compliance rate of 52.1%(278/534). A total of 106 cases of colorectal cancer and precancerous lesions were detected by colonoscopy, with a detection rate of 38.1%(106/278). The compliance rate of colonoscopy in high-risk population group was 80.8%(80/99), which was significantly higher than that in general population group(45.5%), with significant difference(χ²=40.244, P<0.01). The positive rate of colonoscopy in high-risk population group was significantly higher than that in general population, with significant difference(χ²=8.196, P=0.04). 【Conclusion】Hospitalized patients with positive stool occult blood test have high compliance with colonoscopy screening. The compliance rate of high-risk population of colorectal cancer is significantly higher than that of general population. The recommendation of doctors is an important factor affecting screening compliance. Routine screening for colorectal cancer opportunity in hospitalized patients is one of the screening models suitable for China's national conditions.

Key words： Colorectal Neoplasms Inpatients Multiphasic Screening

Received: 06 February 2024

PACS:

R735.35

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHOU Hanshen
	JIA Fenglan
	WANG Tongling

Cite this article:

ZHOU Hanshen,JIA Fenglan,WANG Tongling. Clinical Application Value of Opportunistic Screening for Colorectal Cancer in Hospitalized Patients with Positive Stool Occult Blood Test[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(3): 329-331.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.03.003 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I3/329

[1] 党立力,李进. 错配修复蛋白、Ki-67蛋白表达与老年结直肠癌患者根治术后无进展生存期的关系[J].医学临床研究,2023,40(1):37-40.
[2] 刘浩燕,徐飞. 术后规范化营养干预在老年结直肠癌患者中的应用效果[J].医学临床研究,2023,40(10):1463-1465.
[3] 胡启华,欧爱芝,王蓉,等.肠癌血液多基因甲基化检测对结直肠癌高危人群筛查价值的研究[J].中国现代手术学杂志,2023,27(5):367-372.
[4] LAIRSON D R, DICARLO M, DESHMUK A A, et al. Cost-effectiveness of a standard intervention versus a navigated intervention on colorectal cancer screening use in primary care[J].Cancer,120(7):1042-1049.
[5] 国家消化系统疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟, 中华医学会消化内镜学分会,等. 中国早期结直肠癌筛查流程专家共识意见(2019,上海)[J].中华医学杂志, 2019, 99(38):2961-2970.
[6] 钟选芳,肖丹,许岸高,等.粪便DNA与粪隐血试验机会性筛查大肠肿瘤的比较研究[J].临床消化病杂志,2016,28(2):106-109.
[7] 朱州.加速康复外科在腹腔镜结直肠癌手术围手术期的应用研究[J].中国现代手术学杂志,2018,22(2):122-125.
[8] LIANG P S, DOMINITZ J A.Colorectal cancer screening: Is colonoscopy the best option?[J].Med Clin North Am,2019,103(1):111-123.
[9] CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J].Ca Cancer J Clin,66(2):115-132.
[10] COURTNEY R J, PAUL C L, CAREY M L,et al. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients[J].BMC Cancer,2013,13(1):13.
[11] ALLEMANI C, MATSUDA T, DICARLO V,et al. Global surveillance of trends in cancer survival 2000-14(CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J].Lancet,2018,391(10125):1023-1075.
[12] WOLF A M, FONTHAM E T, CHURCH T R, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society[J].CA Cancer J Clin,2018,68(4):250-281.
[13] LAIRSON D R, DICARLO M, DESHMUK A A, et al. Cost-effectiveness of a standard intervention versus a navigated intervention on colorectal cancer screening use in primary care[J].Cancer,120(7):1042-1049.
[14] 韩英, 武子涛, 盛剑秋,等. 大肠肿瘤伺机性筛查的临床应用探讨[J].中华内科杂志, 2010, 49(7):618-619.